ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD.

Andere Sprachen Zhejiang Jingxin Pharmaceutical Co., Ltd.

Aktien

002020

CNE000001K73

002020

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 10.05.2024			% 5 Tage	% 1. Jan.
12,07 ^CNY	-0,82 %		+1,77 %	-5,11 %

23.04.	Zhejiang Jingxin Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
29.03.	Zhejiang Jingxin Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23.04.
Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023	01.04.
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
Evotec Says Partner Obtained Regulatory Approval in China for Insomnia Drug	06.12.
Jingxin Pharmaceutical Gets Nod to Market Didacinil Capsules	06.12.
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26.10.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	14.08.23
Jingxin Pharma's Unit Gets Nod to Market Eye Drug in Europe	13.06.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2022 Final Profit Distribution Plan, Payable on 24 May 2023	18.05.23
ExoRNA Bio announced that it has received funding from Guangzhou Yuexiu Industrial Investment Fund Management Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Dingxin Capital Co., Ltd., CDH Investment Management Company Limited and other investors	15.05.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25.04.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022	24.04.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	30.03.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27.02.23
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27.10.22
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Directorate Appointments	14.10.22
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25.08.22
Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan, Payable on 25 May 2022	18.05.22
Zhejiang Jingxin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26.04.22
Zhejiang Jingxin Pharmaceutical Co., Ltd. Approves 2021 Profit Distribution Plan At the Annual General Meeting Held on April 22, 2022	25.04.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zhejiang Jingxin Pharmaceutical Co., Ltd.

Aktien

002020

CNE000001K73

002020

Andere Sprachen

Filter